MARSHALL WACE, LLP

Holdings History for BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

Symbol: BCAB on Nasdaq
Investment type: Equity / Common Stocks, par value $0,0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$508,201	891,580	+891,580	NEW	$0.57	Q4 2025
30 Sep 2025		-0%	$0	0	-80,842	-100%	$0.18	Q3 2025
30 Jun 2025	0%	-0%	$32,336	80,842	-5,493	-6.4%	$0.40	Q2 2025
31 Mar 2025	0%	-0%	$30,216	86,335	-286,716		$0.35	Q1 2025
31 Dec 2024	0%	-0%	$220,100	373,051	-63,438	-15%	$0.59	Q4 2024
30 Sep 2024	0%	+0%	$768,222	436,489	+436,489	NEW	$1.76	Q3 2024
31 Mar 2024		-0%	$0	0	-45,383	-100%	$0.18	Q1 2024
31 Dec 2023	0%	+0%	$111,642	45,383	+45,383	NEW	$2.46	Q4 2023
30 Jun 2023		-0%	$0	0	-285,661	-100%	$0.18	Q2 2023
31 Mar 2023	0%	+0%	$765,572	285,661	+247,259	+644%	$2.68	Q1 2023
31 Dec 2022	0%	+0%	$316,818	38,402	+38,402	NEW	$8.25	Q4 2022
30 Sep 2022		-0%	$0	0	-54,557	-100%	$0.18	Q3 2022
30 Jun 2022	0%	-0%	$156,000	54,557	-34,587	-39%	$2.86	Q2 2022
31 Mar 2022	0%	+0%	$445,000	89,144	+58,007	+186%	$4.99	Q1 2022
31 Dec 2021	0%	+0%	$611,000	31,137	+31,137	NEW	$19.62	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.